YME-11136-42902 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-01-08
Dose 1 — Pfizer-BioNTech
2022-01-09
Registered in v-safe
2022-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2022-01-10
Survey response — days 1–6 daily, dose 1
MedDRA: Dysphonia, Oropharyngeal pain — Feeling: Fair · Site: Pain · Fatigue or tiredness

Free text: Hoarse voice and mild sore throat

MedDRA releases: 2024-11 · check-in free text available
2022-01-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2022-01-29
Dose 2 — Pfizer-BioNTech
2022-02-05
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-01-08	Pfizer-BioNTech	No
2	2022-01-29	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 1

2022-01-10

Systemic reaction (other): Hoarse voice and mild sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Dysphonia	·	·	✓
SRO	Oropharyngeal pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release